Serum vitamin D in obese and overweight subjects according to estimated glomerular filtration rate

Objective Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the develo...

Full description

Saved in:
Bibliographic Details
Published inHormones (Athens, Greece) Vol. 17; no. 2; pp. 237 - 246
Main Authors Kitsos, Athanasios, Dounousi, Evangelia, Kalaitzidis, Rigas, Challa, Anna, Siamopoulos, Kostas C., Tigas, Stelios
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.06.2018
Subjects
Online AccessGet full text
ISSN1109-3099
2520-8721
2520-8721
DOI10.1007/s42000-018-0022-8

Cover

Loading…
Abstract Objective Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT). Design Serum 25(OH)D, 1,25(OH) 2 D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m 2 . Participants were categorized according to eGFR (ml/min/1.73m 2 ): G1 ≥ 60 ( n  = 53), G2 30–59 ( n  = 35), and G3 15–29 ( n  = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw ( n  = 23), G2-nw ( n  = 18), and G3-nw ( n  = 9). Results 25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p  = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p  = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p  = 0.030). 1,25(OH) 2 D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m 2 , lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m 2 . Conclusions Lower serum 25(OH)D but similar 1,25(OH) 2 D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined.
AbstractList Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT). Serum 25(OH)D, 1,25(OH) D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m . Participants were categorized according to eGFR (ml/min/1.73m ): G1 ≥ 60 (n = 53), G2 30-59 (n = 35), and G3 15-29 (n = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw (n = 23), G2-nw (n = 18), and G3-nw (n = 9). 25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p = 0.030). 1,25(OH) D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m , lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m . Lower serum 25(OH)D but similar 1,25(OH) D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined.
Objective Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT). Design Serum 25(OH)D, 1,25(OH) 2 D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m 2 . Participants were categorized according to eGFR (ml/min/1.73m 2 ): G1 ≥ 60 ( n  = 53), G2 30–59 ( n  = 35), and G3 15–29 ( n  = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw ( n  = 23), G2-nw ( n  = 18), and G3-nw ( n  = 9). Results 25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p  = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p  = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p  = 0.030). 1,25(OH) 2 D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m 2 , lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m 2 . Conclusions Lower serum 25(OH)D but similar 1,25(OH) 2 D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined.
Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT).OBJECTIVEObesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum vitamin D levels in overweight/obese versus normal-weight individuals according to eGFR and (b) assess the role of 25(OH)D in the development of secondary hyperparathyroidism (SHPT).Serum 25(OH)D, 1,25(OH)2D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m2. Participants were categorized according to eGFR (ml/min/1.73m2): G1 ≥ 60 (n = 53), G2 30-59 (n = 35), and G3 15-29 (n = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw (n = 23), G2-nw (n = 18), and G3-nw (n = 9).DESIGNSerum 25(OH)D, 1,25(OH)2D, parathyroid hormone (PTH), calcium, and phosphate were measured in 104 subjects with BMI > 25 kg/m2. Participants were categorized according to eGFR (ml/min/1.73m2): G1 ≥ 60 (n = 53), G2 30-59 (n = 35), and G3 15-29 (n = 16). Fifty normal-weight individuals with comparable eGFR served as controls: G1-nw (n = 23), G2-nw (n = 18), and G3-nw (n = 9).25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p = 0.030). 1,25(OH)2D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m2, lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m2.RESULTS25(OH)D levels were lower in G1 compared to those in G1-nw (21.7 ± 6.5 vs 26.5 ± 7.0 ng/ml, p = 0.005), G2 versus G2-nw (19.0 ± 6.0 vs 25.0 ± 5.2 ng/ml, p = 0.001), and G3 vs G3-nw (15.8 ± 4.7 vs 20.3 ± 4.5 ng/ml, p = 0.030). 1,25(OH)2D and PTH levels were similar in obese/overweight versus normal-weight individuals in each of the eGFR categories. Factors independently associated with low 25(OH)D levels were BMI > 25 kg/m2, lower eGFR, and female gender. Mean 25(OH)D levels were < 30 ng/ml in both overweight and controls, in all eGFR groups. SHPT was universally observed when eGFR was < 30 ml/min/1.73m2.Lower serum 25(OH)D but similar 1,25(OH)2D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined.CONCLUSIONSLower serum 25(OH)D but similar 1,25(OH)2D and PTH levels were observed in overweight/obese compared to normal-weight individuals. Even though vitamin D insufficiency was common across all eGFR categories, secondary hyperparathyroidism was more prevalent as eGFR declined.
Author Tigas, Stelios
Siamopoulos, Kostas C.
Kalaitzidis, Rigas
Dounousi, Evangelia
Challa, Anna
Kitsos, Athanasios
Author_xml – sequence: 1
  givenname: Athanasios
  surname: Kitsos
  fullname: Kitsos, Athanasios
  organization: Department of Nephrology, University of Ioannina
– sequence: 2
  givenname: Evangelia
  surname: Dounousi
  fullname: Dounousi, Evangelia
  organization: Department of Nephrology, University of Ioannina
– sequence: 3
  givenname: Rigas
  surname: Kalaitzidis
  fullname: Kalaitzidis, Rigas
  organization: Department of Nephrology, University of Ioannina
– sequence: 4
  givenname: Anna
  surname: Challa
  fullname: Challa, Anna
  organization: Pediatric Research Laboratory, Child Health Department, University of Ioannina
– sequence: 5
  givenname: Kostas C.
  surname: Siamopoulos
  fullname: Siamopoulos, Kostas C.
  organization: Department of Nephrology, University of Ioannina
– sequence: 6
  givenname: Stelios
  surname: Tigas
  fullname: Tigas, Stelios
  email: stigas@cc.uoi.gr
  organization: Department of Endocrinology, University of Ioannina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29858844$$D View this record in MEDLINE/PubMed
BookMark eNp9kMFOHSEUQEljU5-2H9CNYelm7AWGGVgata2JSRd1TxjmzisvM6DAaPr35eVpFy7ccDfnXOCckKMQAxLylcEFA-i_5ZYDQANMNQCcN-oD2XDJoVE9Z0dkwxjoRoDWx-Qk5x1AJ7Vin8gx10oq1bYbMvzGtC70yRe7-ECvaT3igBmpDSONT5ie0W__FJrXYYeuZGqdi2n0YUtLpJiLX2zBkW7nuNRVs0108nNJtvgYaB34mXyc7Jzxy8s8Jfffb-6vfjZ3v37cXl3eNU6ovjRDJwHcNMI4TKwXGpllzGmhu0nL0YLiHQolreCql1ZZoa2SjCkOA29xEKfk_LD2IcXHtT7MLD47nGcbMK7ZcGi17EBwXdGzF3QdFhzNQ6qfSH_Na5YKsAPgUsw54fQfYWD26c0hvanpzT69UdXp3ziuRt1XqDH8_K7JD2aut4QtJrOLawq11TvSP_iTl50
CitedBy_id crossref_primary_10_1177_2333794X211018352
crossref_primary_10_3389_fped_2021_696942
Cites_doi 10.1373/clinchem.2012.193003
10.2337/dc10-S062
10.1159/000098561
10.1053/j.ajkd.2014.05.018
10.1210/jc.2010-2704
10.1210/jc.2003-031398
10.1046/j.1523-1755.1999.0550031019.x
10.1053/j.ajkd.2007.04.010
10.1210/jc.2010-0757
10.1053/j.ajkd.2011.12.035
10.1016/j.kisu.2017.04.001
10.1093/ndt/gft360
10.14310/horm.2002.1674
10.1515/hmbci-2015-0069
10.1053/j.jrn.2014.04.005
10.5414/CN108182
10.1053/j.jrn.2013.07.003
10.1007/BF03349258
10.1186/1752-153X-6-112
10.1016/j.nut.2016.06.012
10.1161/HYPERTENSIONAHA.114.03748
10.3390/nu5030949
10.7326/0003-4819-130-6-199903160-00002
10.1093/ajcn/86.4.959
10.1159/000441364
10.1186/1475-2840-11-149
10.3945/ajcn.115.120139
10.1038/sj.ki.5002009
10.1210/jc.2011-0385
ContentType Journal Article
Copyright Hellenic Endocrine Society 2018
Copyright_xml – notice: Hellenic Endocrine Society 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1007/s42000-018-0022-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 2520-8721
EndPage 246
ExternalDocumentID 29858844
10_1007_s42000_018_0022_8
Genre Journal Article
GroupedDBID ---
-EM
0R~
406
53G
AAAVM
AACDK
AAHNG
AAIAL
AAJBT
AASML
AATNV
AAUYE
ABAKF
ABDZT
ABECU
ABFTV
ABJNI
ABKCH
ABMQK
ABQBU
ABTEG
ABTKH
ABTMW
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACMLO
ACOKC
ACPIV
ACZOJ
ADBBV
ADKNI
ADRFC
ADTPH
ADURQ
ADYFF
AEFQL
AEJRE
AEMSY
AEOHA
AESKC
AFBBN
AFQWF
AGDGC
AGJBK
AGMZJ
AGQEE
AGRTI
AIAKS
AIGIU
AILAN
AITGF
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AMYQR
AXYYD
BAWUL
BGNMA
CSCUP
DIK
DPUIP
EBLON
EBS
EJD
F5P
FIGPU
FINBP
FNLPD
FRP
FSGXE
GGCAI
HG6
IKXTQ
IWAJR
J-C
JZLTJ
LLZTM
M4Y
NPVJJ
NQJWS
NU0
O9J
OK1
PT4
RLLFE
ROL
RSV
SISQX
SJYHP
SNE
SNPRN
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
TR2
TSG
UOJIU
UTJUX
UZXMN
VFIZW
ZMTXR
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ABRTQ
ID FETCH-LOGICAL-c387t-b6500cfd0dbf1739e1a11c9396f95da0826e385a32875a8a39a8511820b24eb3
ISSN 1109-3099
2520-8721
IngestDate Thu Sep 04 15:25:46 EDT 2025
Wed Feb 19 02:42:42 EST 2025
Tue Jul 01 03:52:04 EDT 2025
Thu Apr 24 22:55:04 EDT 2025
Fri Feb 21 02:34:59 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Obesity
Vitamin D
D
PTH
25(OH)D
1,25(OH)
Chronic kidney disease
Secondary hyperparathyroidism
1,25(OH)2D
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c387t-b6500cfd0dbf1739e1a11c9396f95da0826e385a32875a8a39a8511820b24eb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://link.springer.com/content/pdf/10.1007/s42000-018-0022-8.pdf
PMID 29858844
PQID 2049560329
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_2049560329
pubmed_primary_29858844
crossref_primary_10_1007_s42000_018_0022_8
crossref_citationtrail_10_1007_s42000_018_0022_8
springer_journals_10_1007_s42000_018_0022_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20180600
2018-6-00
2018-Jun
20180601
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 6
  year: 2018
  text: 20180600
PublicationDecade 2010
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Switzerland
PublicationSubtitle International Journal of Endocrinology and Metabolism
PublicationTitle Hormones (Athens, Greece)
PublicationTitleAbbrev Hormones
PublicationTitleAlternate Hormones (Athens)
PublicationYear 2018
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References GuessousIMcClellanWKleinbaumDComparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based studyJ Ren Nutr201424530331210.1053/j.jrn.2014.04.005250302231:CAS:528:DC%2BC2cXhtFGmtbnO
LundwallKJorneskogGJacobsonSHSpaakJParicalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trialAm J Nephrol201542426527310.1159/000441364264962101:CAS:528:DC%2BC2MXhvFKhs7%2FL
EknoyanGObesity and chronic kidney diseaseNefrologia2011314397403216233931:STN:280:DC%2BC3Mjot1aitQ%3D%3D
HolickMFBinkleyNCBischoff-FerrariHAEvaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab20119671911193010.1210/jc.2011-0385216463681:CAS:528:DC%2BC3MXptlSku7o%3D
LeveyASBoschJPLewisJBGreeneTRogersNRothDA more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupAnn Intern Med 161999130646147010.7326/0003-4819-130-6-199903160-000021:CAS:528:DyaK1MXitFChs7k%3D
SergeevIN1,25-Dihydroxyvitamin D3 and type 2 diabetes: Ca2+−dependent molecular mechanisms and the role of vitamin D statusHorm Mol Biol Clin Investig20162616165268768151:CAS:528:DC%2BC28XpsFGqurc%3D
TzotzasTPapadopoulouFGTziomalosKRising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistanceJ Clin Endocrinol Metab20109594251425710.1210/jc.2010-0757205347511:CAS:528:DC%2BC3cXht1Wms7zJ
National Kidney FoundationK/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis2002392 Suppl 1S1
NigwekarSUBhanIThadhaniRErgocalciferol and cholecalciferol in CKDAm J Kidney Dis201260113915610.1053/j.ajkd.2011.12.035225608321:CAS:528:DC%2BC38Xmslyhu7w%3D
PapapetrouPDTriantafyllopoulouMKorakovouniASevere vitamin D deficiency in the institutionalized elderlyJ Endocrinol Investig200831978478710.1007/BF033492581:CAS:528:DC%2BC3cXisVGhs70%3D
Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation200217, 1062531433421
KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:S1–S59
LevinABakrisGLMolitchMPrevalence of abnormal serum vitamin D, PTH, calcium, and phosphate in patients with chronic kidney disease: results of the study to evaluate early kidney diseaseKidney Int2007711313810.1038/sj.ki.5002009170911241:CAS:528:DC%2BD28XhtlSqtbnK
European health interview survey. http://ec.europa.eu/eurostat. Published online October 20, 2016
MolinaPGorrizJLMolinaMDThe effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled studyNephrol Dial Transplant20142919710910.1093/ndt/gft360239758421:CAS:528:DC%2BC2cXmt1yqtg%3D%3D
WalshJSEvansALBowlesSFree 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone healthAm J Clin Nutr201610361465147110.3945/ajcn.115.120139271698391:CAS:528:DC%2BC28Xhs1Gis7fN
ZismanALHristovaMHoLTSpragueSMImpact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney diseaseAm J Nephrol2007271364310.1159/000098561172155731:CAS:528:DC%2BD2sXisFygsr8%3D
NgaiMLinVWongHCVathsalaAHowPVitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease populationClin Nephrol201482423123910.5414/CN108182251611151:CAS:528:DC%2BC2cXitVyltL%2FI
RossACMansonJEAbramsSAThe 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to knowJ Clin Endocrinol Metab2011961535810.1210/jc.2010-2704211188271:CAS:528:DC%2BC3MXhtFGntbg%3D
Barreto SilvaMICavalieriVVLemosCCKleinMRBregmanRBody adiposity predictors of vitamin D status in nondialyzed patients with chronic kidney disease: a cross-sectional analysis in a tropical climate cityNutrition20173324024710.1016/j.nut.2016.06.012276929901:CAS:528:DC%2BC28Xhs1Sisr%2FK
ParikhSJEdelmanMUwaifoGIThe relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adultsJ Clin Endocrinol Metab20048931196119910.1210/jc.2003-031398150016091:CAS:528:DC%2BD2cXisVWrurY%3D
World Health Organization 2000 Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series (894). Geneva, Switzerland: WHO. Available at: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en
MartinKJGonzálezEAVitamin D supplementation in CKDClin Nephrol2011754286293214268821:CAS:528:DC%2BC3MXntlKgtrw%3D
VanlintSVitamin D and obesityNutrients Mar20135394995610.3390/nu50309491:CAS:528:DC%2BC3sXkvVajtL8%3D
KatrinakiMKampaMMargiorisACastanasEMalliarakiNVitamin D levels in a large Mediterranean cohort: reconsidering normal cut-off valuesHormones (Athens)201615220522310.14310/horm.2002.1674
American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201033Suppl 1S62S6910.2337/dc10-S0622797383
ShahIPetrocziANaughtonDPMethod for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometryChem Cent J20121;61112
AfzalSBojesenSENordestgaardBGLow 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysisClin Chem201359238139110.1373/clinchem.2012.193003232320641:CAS:528:DC%2BC3sXhvFOgsL8%3D
BollandMJGreyABAmesRWThe effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiencyAm J Clin Nutr2007864959642810.1093/ajcn/86.4.959179213711:CAS:528:DC%2BD2sXhtFyks7nO
KimSMChoiHJLeeJPPrevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney diseaseJ Ren Nutr2014241202510.1053/j.jrn.2013.07.003242162581:CAS:528:DC%2BC3sXhslGls7jN
Al-AlyZQaziRAGonzálezEAZeringueAMartinKJChanges in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKDAm J Kidney Dis2007501596810.1053/j.ajkd.2007.04.010175915251:CAS:528:DC%2BD2sXosVKksrg%3D
KramerHBernsJSChoiMJMartinKRoccoMV25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies reportAm J Kidney Dis201464449950910.1053/j.ajkd.2014.05.018250821011:CAS:528:DC%2BC2cXhtlaiurjL
LagunovaZPorojnicuALindbergFHexebergSMoanJThe dependency of vitamin D status on body mass index, gender, age and seasonAnticancer Res200929937133720196671691:CAS:528:DC%2BD1MXhtVKku7fF
ZoccaliCCuratolaGPanuccioVParicalcitol and endothelial function in chronic kidney disease trialHypertension20146451005101110.1161/HYPERTENSIONAHA.114.03748252597431:CAS:528:DC%2BC2cXhvVSnsrjP
IshimuraENishizawaYInabaMSerum levels of 1,25- dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failureKidney Int1999551019102710.1046/j.1523-1755.1999.0550031019.x100279391:STN:280:DyaK1M7lt1ahtw%3D%3D
GuaschABullóMRabassaABonadaADel CastilloDSabenchFSalas-SalvadóJPlasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional studyCardiovasc Diabetol2012111114910.1186/1475-2840-11-1492322819835410711:CAS:528:DC%2BC3sXjslCis7s%3D
K Lundwall (22_CR10) 2015; 42
AS Levey (22_CR15) 1999; 130
Z Al-Aly (22_CR32) 2007; 50
National Kidney Foundation (22_CR16) 2002; 39
MF Holick (22_CR6) 2011; 96
IN Sergeev (22_CR35) 2016; 26
M Ngai (22_CR25) 2014; 82
M Katrinaki (22_CR21) 2016; 15
Z Lagunova (22_CR5) 2009; 29
AL Zisman (22_CR33) 2007; 27
S Afzal (22_CR34) 2013; 59
22_CR8
22_CR14
E Ishimura (22_CR30) 1999; 55
P Molina (22_CR12) 2014; 29
22_CR1
A Guasch (22_CR22) 2012; 11
Third Report of the National Cholesterol Education Program (NCEP) (22_CR18) 2002; 17, 106
SJ Parikh (22_CR4) 2004; 89
C Zoccali (22_CR11) 2014; 64
I Shah (22_CR24) 2012; 1;6
JS Walsh (22_CR23) 2016; 103
KJ Martin (22_CR31) 2011; 75
S Vanlint (22_CR3) 2013; 5
A Levin (22_CR26) 2007; 71
I Guessous (22_CR28) 2014; 24
PD Papapetrou (22_CR19) 2008; 31
American Diabetes Association (22_CR17) 2010; 33
T Tzotzas (22_CR20) 2010; 95
H Kramer (22_CR9) 2014; 64
AC Ross (22_CR29) 2011; 96
G Eknoyan (22_CR2) 2011; 31
MI Barreto Silva (22_CR13) 2017; 33
MJ Bolland (22_CR36) 2007; 86
SM Kim (22_CR27) 2014; 24
SU Nigwekar (22_CR7) 2012; 60
References_xml – reference: KramerHBernsJSChoiMJMartinKRoccoMV25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies reportAm J Kidney Dis201464449950910.1053/j.ajkd.2014.05.018250821011:CAS:528:DC%2BC2cXhtlaiurjL
– reference: BollandMJGreyABAmesRWThe effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiencyAm J Clin Nutr2007864959642810.1093/ajcn/86.4.959179213711:CAS:528:DC%2BD2sXhtFyks7nO
– reference: World Health Organization 2000 Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series (894). Geneva, Switzerland: WHO. Available at: http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/
– reference: KimSMChoiHJLeeJPPrevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney diseaseJ Ren Nutr2014241202510.1053/j.jrn.2013.07.003242162581:CAS:528:DC%2BC3sXhslGls7jN
– reference: GuessousIMcClellanWKleinbaumDComparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based studyJ Ren Nutr201424530331210.1053/j.jrn.2014.04.005250302231:CAS:528:DC%2BC2cXhtFGmtbnO
– reference: KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:S1–S59
– reference: LundwallKJorneskogGJacobsonSHSpaakJParicalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trialAm J Nephrol201542426527310.1159/000441364264962101:CAS:528:DC%2BC2MXhvFKhs7%2FL
– reference: ZismanALHristovaMHoLTSpragueSMImpact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney diseaseAm J Nephrol2007271364310.1159/000098561172155731:CAS:528:DC%2BD2sXisFygsr8%3D
– reference: AfzalSBojesenSENordestgaardBGLow 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysisClin Chem201359238139110.1373/clinchem.2012.193003232320641:CAS:528:DC%2BC3sXhvFOgsL8%3D
– reference: LagunovaZPorojnicuALindbergFHexebergSMoanJThe dependency of vitamin D status on body mass index, gender, age and seasonAnticancer Res200929937133720196671691:CAS:528:DC%2BD1MXhtVKku7fF
– reference: LeveyASBoschJPLewisJBGreeneTRogersNRothDA more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupAnn Intern Med 161999130646147010.7326/0003-4819-130-6-199903160-000021:CAS:528:DyaK1MXitFChs7k%3D
– reference: EknoyanGObesity and chronic kidney diseaseNefrologia2011314397403216233931:STN:280:DC%2BC3Mjot1aitQ%3D%3D
– reference: Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation200217, 1062531433421
– reference: MolinaPGorrizJLMolinaMDThe effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled studyNephrol Dial Transplant20142919710910.1093/ndt/gft360239758421:CAS:528:DC%2BC2cXmt1yqtg%3D%3D
– reference: RossACMansonJEAbramsSAThe 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to knowJ Clin Endocrinol Metab2011961535810.1210/jc.2010-2704211188271:CAS:528:DC%2BC3MXhtFGntbg%3D
– reference: ParikhSJEdelmanMUwaifoGIThe relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adultsJ Clin Endocrinol Metab20048931196119910.1210/jc.2003-031398150016091:CAS:528:DC%2BD2cXisVWrurY%3D
– reference: HolickMFBinkleyNCBischoff-FerrariHAEvaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab20119671911193010.1210/jc.2011-0385216463681:CAS:528:DC%2BC3MXptlSku7o%3D
– reference: VanlintSVitamin D and obesityNutrients Mar20135394995610.3390/nu50309491:CAS:528:DC%2BC3sXkvVajtL8%3D
– reference: LevinABakrisGLMolitchMPrevalence of abnormal serum vitamin D, PTH, calcium, and phosphate in patients with chronic kidney disease: results of the study to evaluate early kidney diseaseKidney Int2007711313810.1038/sj.ki.5002009170911241:CAS:528:DC%2BD28XhtlSqtbnK
– reference: ShahIPetrocziANaughtonDPMethod for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometryChem Cent J20121;61112
– reference: WalshJSEvansALBowlesSFree 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone healthAm J Clin Nutr201610361465147110.3945/ajcn.115.120139271698391:CAS:528:DC%2BC28Xhs1Gis7fN
– reference: PapapetrouPDTriantafyllopoulouMKorakovouniASevere vitamin D deficiency in the institutionalized elderlyJ Endocrinol Investig200831978478710.1007/BF033492581:CAS:528:DC%2BC3cXisVGhs70%3D
– reference: TzotzasTPapadopoulouFGTziomalosKRising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistanceJ Clin Endocrinol Metab20109594251425710.1210/jc.2010-0757205347511:CAS:528:DC%2BC3cXht1Wms7zJ
– reference: American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201033Suppl 1S62S6910.2337/dc10-S0622797383
– reference: IshimuraENishizawaYInabaMSerum levels of 1,25- dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failureKidney Int1999551019102710.1046/j.1523-1755.1999.0550031019.x100279391:STN:280:DyaK1M7lt1ahtw%3D%3D
– reference: KatrinakiMKampaMMargiorisACastanasEMalliarakiNVitamin D levels in a large Mediterranean cohort: reconsidering normal cut-off valuesHormones (Athens)201615220522310.14310/horm.2002.1674
– reference: Al-AlyZQaziRAGonzálezEAZeringueAMartinKJChanges in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKDAm J Kidney Dis2007501596810.1053/j.ajkd.2007.04.010175915251:CAS:528:DC%2BD2sXosVKksrg%3D
– reference: NgaiMLinVWongHCVathsalaAHowPVitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease populationClin Nephrol201482423123910.5414/CN108182251611151:CAS:528:DC%2BC2cXitVyltL%2FI
– reference: National Kidney FoundationK/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis2002392 Suppl 1S1
– reference: ZoccaliCCuratolaGPanuccioVParicalcitol and endothelial function in chronic kidney disease trialHypertension20146451005101110.1161/HYPERTENSIONAHA.114.03748252597431:CAS:528:DC%2BC2cXhvVSnsrjP
– reference: MartinKJGonzálezEAVitamin D supplementation in CKDClin Nephrol2011754286293214268821:CAS:528:DC%2BC3MXntlKgtrw%3D
– reference: GuaschABullóMRabassaABonadaADel CastilloDSabenchFSalas-SalvadóJPlasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional studyCardiovasc Diabetol2012111114910.1186/1475-2840-11-1492322819835410711:CAS:528:DC%2BC3sXjslCis7s%3D
– reference: NigwekarSUBhanIThadhaniRErgocalciferol and cholecalciferol in CKDAm J Kidney Dis201260113915610.1053/j.ajkd.2011.12.035225608321:CAS:528:DC%2BC38Xmslyhu7w%3D
– reference: European health interview survey. http://ec.europa.eu/eurostat. Published online October 20, 2016
– reference: Barreto SilvaMICavalieriVVLemosCCKleinMRBregmanRBody adiposity predictors of vitamin D status in nondialyzed patients with chronic kidney disease: a cross-sectional analysis in a tropical climate cityNutrition20173324024710.1016/j.nut.2016.06.012276929901:CAS:528:DC%2BC28Xhs1Sisr%2FK
– reference: SergeevIN1,25-Dihydroxyvitamin D3 and type 2 diabetes: Ca2+−dependent molecular mechanisms and the role of vitamin D statusHorm Mol Biol Clin Investig20162616165268768151:CAS:528:DC%2BC28XpsFGqurc%3D
– ident: 22_CR14
– volume: 59
  start-page: 381
  issue: 2
  year: 2013
  ident: 22_CR34
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2012.193003
– volume: 33
  start-page: S62
  issue: Suppl 1
  year: 2010
  ident: 22_CR17
  publication-title: Diabetes Care
  doi: 10.2337/dc10-S062
– volume: 27
  start-page: 36
  issue: 1
  year: 2007
  ident: 22_CR33
  publication-title: Am J Nephrol
  doi: 10.1159/000098561
– volume: 64
  start-page: 499
  issue: 4
  year: 2014
  ident: 22_CR9
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2014.05.018
– volume: 96
  start-page: 53
  issue: 1
  year: 2011
  ident: 22_CR29
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-2704
– volume: 39
  start-page: S1
  issue: 2 Suppl 1
  year: 2002
  ident: 22_CR16
  publication-title: Am J Kidney Dis
– volume: 89
  start-page: 1196
  issue: 3
  year: 2004
  ident: 22_CR4
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-031398
– ident: 22_CR1
– volume: 55
  start-page: 1019
  year: 1999
  ident: 22_CR30
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1999.0550031019.x
– volume: 31
  start-page: 397
  issue: 4
  year: 2011
  ident: 22_CR2
  publication-title: Nefrologia
– volume: 50
  start-page: 59
  issue: 1
  year: 2007
  ident: 22_CR32
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2007.04.010
– volume: 95
  start-page: 4251
  issue: 9
  year: 2010
  ident: 22_CR20
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-0757
– volume: 60
  start-page: 139
  issue: 1
  year: 2012
  ident: 22_CR7
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2011.12.035
– ident: 22_CR8
  doi: 10.1016/j.kisu.2017.04.001
– volume: 29
  start-page: 97
  issue: 1
  year: 2014
  ident: 22_CR12
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft360
– volume: 15
  start-page: 205
  issue: 2
  year: 2016
  ident: 22_CR21
  publication-title: Hormones (Athens)
  doi: 10.14310/horm.2002.1674
– volume: 26
  start-page: 61
  issue: 1
  year: 2016
  ident: 22_CR35
  publication-title: Horm Mol Biol Clin Investig
  doi: 10.1515/hmbci-2015-0069
– volume: 24
  start-page: 303
  issue: 5
  year: 2014
  ident: 22_CR28
  publication-title: J Ren Nutr
  doi: 10.1053/j.jrn.2014.04.005
– volume: 82
  start-page: 231
  issue: 4
  year: 2014
  ident: 22_CR25
  publication-title: Clin Nephrol
  doi: 10.5414/CN108182
– volume: 24
  start-page: 20
  issue: 1
  year: 2014
  ident: 22_CR27
  publication-title: J Ren Nutr
  doi: 10.1053/j.jrn.2013.07.003
– volume: 75
  start-page: 286
  issue: 4
  year: 2011
  ident: 22_CR31
  publication-title: Clin Nephrol
– volume: 31
  start-page: 784
  issue: 9
  year: 2008
  ident: 22_CR19
  publication-title: J Endocrinol Investig
  doi: 10.1007/BF03349258
– volume: 1;6
  start-page: 112
  issue: 1
  year: 2012
  ident: 22_CR24
  publication-title: Chem Cent J
  doi: 10.1186/1752-153X-6-112
– volume: 33
  start-page: 240
  year: 2017
  ident: 22_CR13
  publication-title: Nutrition
  doi: 10.1016/j.nut.2016.06.012
– volume: 64
  start-page: 1005
  issue: 5
  year: 2014
  ident: 22_CR11
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.114.03748
– volume: 5
  start-page: 949
  issue: 3
  year: 2013
  ident: 22_CR3
  publication-title: Nutrients Mar
  doi: 10.3390/nu5030949
– volume: 130
  start-page: 461
  issue: 6
  year: 1999
  ident: 22_CR15
  publication-title: Ann Intern Med 16
  doi: 10.7326/0003-4819-130-6-199903160-00002
– volume: 17, 106
  start-page: 3143
  issue: 25
  year: 2002
  ident: 22_CR18
  publication-title: Circulation
– volume: 86
  start-page: 959
  issue: 4
  year: 2007
  ident: 22_CR36
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/86.4.959
– volume: 42
  start-page: 265
  issue: 4
  year: 2015
  ident: 22_CR10
  publication-title: Am J Nephrol
  doi: 10.1159/000441364
– volume: 11
  start-page: 149
  issue: 11
  year: 2012
  ident: 22_CR22
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/1475-2840-11-149
– volume: 103
  start-page: 1465
  issue: 6
  year: 2016
  ident: 22_CR23
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.115.120139
– volume: 71
  start-page: 31
  issue: 1
  year: 2007
  ident: 22_CR26
  publication-title: Kidney Int
  doi: 10.1038/sj.ki.5002009
– volume: 29
  start-page: 3713
  issue: 9
  year: 2009
  ident: 22_CR5
  publication-title: Anticancer Res
– volume: 96
  start-page: 1911
  issue: 7
  year: 2011
  ident: 22_CR6
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-0385
SSID ssj0065981
Score 2.1248043
Snippet Objective Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare...
Obesity and renal disease are both associated with low serum 25(OH)D. The aims of the present study were to (a) assess vitamin D status and compare serum...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 237
SubjectTerms Adolescent
Adult
Aged
Endocrinology
Female
Glomerular Filtration Rate
Humans
Hydroxycholecalciferols - blood
Hyperparathyroidism, Secondary - blood
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Obesity - blood
Original Article
Overweight - blood
Parathyroid Hormone - blood
Young Adult
Title Serum vitamin D in obese and overweight subjects according to estimated glomerular filtration rate
URI https://link.springer.com/article/10.1007/s42000-018-0022-8
https://www.ncbi.nlm.nih.gov/pubmed/29858844
https://www.proquest.com/docview/2049560329
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaW7YULAspjeclIiANRqiTOwzmmLdWKih7QIvUWOY6zSrWbVCSLRMWPZ8bOC5Yi4BKtsokj5fsy_mY8MybkTZHzSIAysBnMThi6gU_Ky6TNi1yyMIIZUddXfLwIl5_9D5fB5Wz2fVpd0mZH8ua3dSX_gyqcA1yxSvYfkB0GhRPwG_CFIyAMx7_CGD703db6Cu79tqysU4xd1JlqzIpArVOe0fe2ml12pbM2hERnU1dI1Rb21wC9Copzvam3MBQmpBblpmuka2ETial2XYK8xc7-KEoTbJrQdEUuSqpJQOG8bBuTu5dgWF40ZT1uXg-2pd41OoMANfxabcphXjgXG1G2N2Vu2h58KtdiuPEE93wxIeDK7PfdhypcPqZUHSlt0rwAnFUemZrowf5GE555U2Nq2sHsGXmT19H4pioeH4MlCXx6LeB0vdWoezHHWlx_nO-GLMT-rzvkwAMnw5mTg-Ts-Piin8nDIOZuvxKO5Za_PhE7SXdj_Cxr9nyVvXV2LV9W98m9zu-giSHRAzJT1UNymFSirbff6FuqM4H1EsshyTSvaMcrekrhoHlFgVd05BXteUUHXtG2pgOv6MgrOvKKIq8ekdXZ-9XJ0u724rAl41FrZ6DkHVnkTp4VbsRi5QrXlTGLwyIOcgFCMlSMB4KBBx4ILlgsuHZenczzVcYek3kFFH1KqCyiCNvVexFXPi-8WIIVCXOuYl84TPgL4vRvMpVdn3rcLmWTDh22NQ4p4JAiDilfkHfDLdemScufLn7dw5OCKcX1MVEp4H7qOTpawLx4QZ4Y3IbhepwXxOqBTDtL0Nz-rGe3jvOc3B2_kBdk3n7ZqZcgb9vsVcfCH0EdonE
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+vitamin+D+in+obese+and+overweight+subjects+according+to+estimated+glomerular+filtration+rate&rft.jtitle=Hormones+%28Athens%2C+Greece%29&rft.au=Kitsos%2C+Athanasios&rft.au=Dounousi%2C+Evangelia&rft.au=Kalaitzidis%2C+Rigas&rft.au=Challa%2C+Anna&rft.date=2018-06-01&rft.eissn=2520-8721&rft.volume=17&rft.issue=2&rft.spage=237&rft_id=info:doi/10.1007%2Fs42000-018-0022-8&rft_id=info%3Apmid%2F29858844&rft.externalDocID=29858844
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1109-3099&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1109-3099&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1109-3099&client=summon